Editorial
Early Use of Insulin in the Management of Type 2 Diabetes—The Time is Now
Abstract
Recently the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) have published guidelines that describe a consensus approach to the management of hyperglycemia in patients with type 2 diabetes.1 While effective weight loss, increased physical activity, and dietary control remain the pillars of therapy, the inability of many patients to successfully institute lifestyle changes and reach glycemic goals has prompted new recommendations from the leading professional groups. One of the hallmarks of the new recommendations is the earlier use of insulin therapy.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.